title: A graphical method to compare the in vivo binding potential of PET radioligands in the absence of a reference region: application to [¹¹C]PBR28 and [¹⁸F]PBR111 for TSPO imaging.
abstract: Positron emission tomography (PET) radioligands for a reversible central nervous system (CNS) demand a high specific to nonspecific signal characterized by the binding potential (BPND). The quantification of BPND requires the determination of the nondisplaceable binding usually derived from a reference region devoid of the target of interest. However, for many CNS targets, there is no valid reference region available. In such cases, the total volume of distribution (VT) is often used as the outcome measure, which includes both the specific and nonspecific binding signals. Here we present a graphical method that allows for direct comparison of the binding potential of ligands using the regional VT data alone via linear regression. The method was first validated using literature data for five serotonin transporter ligands, for which a reference region exists, and then applied to two second generation 18 kDa translocator protein radioligands, namely [(11)C]PBR28 and [(18)F]PBR111. The analysis determined that [(11)C]PBR28 had a higher BPND than [(18)F]PBR111.
authors.affiliation: 1] Centre for Neuroimaging Sciences, Institute of Psychiatry, King's College London, London, UK [2] Imanova, Centre for Imaging Sciences, London, UK [3] Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK.
authors.forename: Qi
authors.initials: Q
authors.lastname: Guo
authors.affiliation: Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK.
authors.forename: David R
authors.initials: DR
authors.lastname: Owen
authors.affiliation: 1] Centre for Neuroimaging Sciences, Institute of Psychiatry, King's College London, London, UK [2] Imanova, Centre for Imaging Sciences, London, UK.
authors.forename: Eugenii A
authors.initials: EA
authors.lastname: Rabiner
authors.affiliation: Centre for Neuroimaging Sciences, Institute of Psychiatry, King's College London, London, UK.
authors.forename: Federico E
authors.initials: FE
authors.lastname: Turkheimer
authors.affiliation: 1] Imanova, Centre for Imaging Sciences, London, UK [2] Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK [3] Department of Engineering Science, University of Oxford, Oxford, UK.
authors.forename: Roger N
authors.initials: RN
authors.lastname: Gunn
mesh_terms: D000465:Algorithms; D001921:Brain / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008024:Ligands; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*
chemical_list: D008024:Ligands; D019275:Radiopharmaceuticals
references.citation: Neuroimage. 2011 Jan 1;54(1):264-77
references.pmid: 20600980
references.citation: Neuroimage. 2012 Apr 2;60(2):902-10
references.pmid: 22251896
references.citation: Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):352-7
references.pmid: 21085954
references.citation: J Cereb Blood Flow Metab. 2010 Jan;30(1):46-50
references.pmid: 19738632
references.citation: J Cereb Blood Flow Metab. 1995 Jan;15(1):152-65
references.pmid: 7798333
references.citation: Pharm Res. 2003 Jul;20(7):1015-21
references.pmid: 12880287
references.citation: Neuroimage. 2008 Mar 1;40(1):43-52
references.pmid: 18093844
references.citation: J Cereb Blood Flow Metab. 1983 Mar;3(1):1-7
references.pmid: 6822610
references.citation: Ann Neurol. 1984 Mar;15(3):217-27
references.pmid: 6609679
references.citation: J Cereb Blood Flow Metab. 2012 Jan;32(1):1-5
references.pmid: 22008728
references.citation: J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
references.pmid: 17519979
references.citation: Synapse. 2005 Mar 1;55(3):164-75
references.pmid: 15605360
references.citation: J Nucl Med. 2009 Oct;50(10):1715-23
references.pmid: 19759115
references.citation: J Cereb Blood Flow Metab. 2012 May;32(5):874-83
references.pmid: 22274741
references.citation: J Cereb Blood Flow Metab. 2002 Nov;22(11):1377-98
references.pmid: 12439295
references.citation: Med Inform (Lond). 1985 Apr-Jun;10(2):137-42
references.pmid: 4021648
references.citation: Nucl Med Biol. 2000 Jul;27(5):477-82
references.pmid: 10962254
references.citation: J Med Chem. 2013 Jun 13;56(11):4568-79
references.pmid: 23651455
references.citation: J Cereb Blood Flow Metab. 2002 Feb;22(2):240-4
references.pmid: 11823722
references.citation: Synapse. 2011 Jul;65(7):624-33
references.pmid: 21484882
references.citation: J Nucl Med. 2000 Dec;41(12):2083-8
references.pmid: 11138696
references.citation: J Cereb Blood Flow Metab. 2013 Jan;33(1):53-8
references.pmid: 22968319
references.citation: J Med Chem. 2008 Jul 10;51(13):3700-12
references.pmid: 18557607
references.citation: J Nucl Med. 2007 Dec;48(12):2072-9
references.pmid: 18006619
references.citation: J Nucl Med. 2011 Jan;52(1):24-32
references.pmid: 21149489
references.citation: J Nucl Med. 2013 Nov;54(11):1915-23
references.pmid: 24071511
references.citation: Stat Med. 2003 Nov 30;22(22):3557-68
references.pmid: 14601019
references.citation: J Cereb Blood Flow Metab. 1990 Sep;10(5):740-7
references.pmid: 2384545
references.citation: Glia. 2002 Nov;40(2):206-17
references.pmid: 12379908